Bristol Myers Squibb today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi® (lisocabtagene maraleucel; ...
The Biden administration - in its final weeks - quietly stacked a key health committee in a move that could sabotage Robert F ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback